871700-24-2

Basic information

• Product Name: 3-cyclopropyl-1-(2-fluoro-4-iodophenyl)-5-hydroxy-6,8-diMethylpyrido[2,3-d]pyriMidine-2,4,7(1H,3H,8H)-trione
• Synonyms: 3-cyclopropyl-1-(2-fluoro-4-iodophenyl)-5-hydroxy-6,8-diMethylpyrido[2,3-d]pyriMidine-2,4,7(1H,3H,8H)-trione;CB42623933;3-Cyclopropyl-1-(2-fluoro-4-iodophenyl)-5-hydroxy-6,8-dimethyl-1H,8H-pyrido[2,3-d]pyrimidine-2,4,7-trione;3-Cyclopropyl-1-(2-fluoro-4-iodophenyl)-5-hydroxy-6,8-dimethylpyrido[2,3-d]pyrimidine-2,4,7(1H
• CAS NO: 871700-24-2
• Molecular Formula: C₁₈H₁₅FIN₃O₄
• Molecular Weight: 483.2322732
• Mol File: 871700-24-2.mol

Chemical Properties

• Boiling Point: 518.2±60.0 °C(Predicted)
• Appearance: /
• Density: 1.94±0.1 g/cm3(Predicted)
• Storage Temp.: 2-8°C(protect from light)
• PKA: 4.50±1.00(Predicted)
• CAS DataBase Reference: 3-cyclopropyl-1-(2-fluoro-4-iodophenyl)-5-hydroxy-6,8-diMethylpyrido[2,3-d]pyriMidine-2,4,7(1H,3H,8H)-trione(CAS DataBase Reference)
• NIST Chemistry Reference: 3-cyclopropyl-1-(2-fluoro-4-iodophenyl)-5-hydroxy-6,8-diMethylpyrido[2,3-d]pyriMidine-2,4,7(1H,3H,8H)-trione(871700-24-2)
• EPA Substance Registry System: 3-cyclopropyl-1-(2-fluoro-4-iodophenyl)-5-hydroxy-6,8-diMethylpyrido[2,3-d]pyriMidine-2,4,7(1H,3H,8H)-trione(871700-24-2)

Safety Data

• Hazardous Substances Data: 871700-24-2(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
3-cyclopropyl-1-(2-fluoro-4-iodophenyl)-5-hydroxy-6,8-dimethylpyrido[2,3-d]pyrimidine-2,4,7(1H,3H,8H)-trione is used as a potential pharmaceutical agent for its possible interactions with biological targets, which may contribute to the development of new drugs or therapeutic agents. Its unique structural features and functional groups could be leveraged to modulate specific biological pathways or target certain diseases.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, 3-cyclopropyl-1-(2-fluoro-4-iodophenyl)-5-hydroxy-6,8-dimethylpyrido[2,3-d]pyrimidine-2,4,7(1H,3H,8H)-trione serves as a subject of study for understanding its chemical properties, reactivity, and potential mechanisms of action. This knowledge can be applied to optimize its pharmaceutical potential and guide the design of related compounds with improved efficacy and selectivity.
Used in Drug Discovery:
3-cyclopropyl-1-(2-fluoro-4-iodophenyl)-5-hydroxy-6,8-dimethylpyrido[2,3-d]pyrimidine-2,4,7(1H,3H,8H)-trione is utilized in drug discovery processes to identify and develop new therapeutic agents. Its unique structural elements and functional groups may offer novel avenues for targeting specific diseases or conditions, contributing to the advancement of medicine and healthcare.

Upstream product

• 871700-22-0 3-cyclopropyl-1-(2-fluoro-4-iodophenyl)-6-methylamino-1H-pyrimidine-2,4-dione 
• 516-05-2 methyl-propanedioic acid 
• 871700-23-1 1-cyclopropyl-3-(2-fluoro-4-iodophenyl)-6-methylamino-1H-pyrimidine-2,4-dione 
• 871700-18-4 N-(2-fluoro-4-iodophenyl)-N'-cyclopropylurea 

Downstream Products

• 871700-07-1 trifluoromethanesulfonic acid 3-cyclopropyl-1-(2-fluoro-4-iodophenyl)-6,8-dimethyl-2,4,7-trioxo-1,2,3,4,7,8-hexahydro-pyrido[2,3-d]pyrimidin-5-yl ester 
• 871700-32-2 3-cyclopropyl-1-(2-fluoro-4-iodophenyl)-6,8-dimethyl-2,4,7-trioxo-1,2,3,4,7,8-hexahydropyrido[2,3-d]pyrimidin-5-yl 4-methylbenzenesulfonate 

Relevant articles and documents

Method for synthesizing key intermediate of trametinib

The invention discloses a method for synthesizing a key intermediate of trametinib, malonic acid monomethyl amide monoethyl ester and isosuccinic acid have a ring-closure reaction to obtain a crude product of a pyridine triketone compound; the obtained cr

5-AMINO-2,4,7-TRIOXO-3,4,7,8-TETRAHYDRO-2H-PYRIDO’2,3-D! PYRIMIDINE DERIVATIVES AND RELATED COMPOUNDS FOR THE TREATMENT OF CANCER

The present invention relates to a pyrimidine compound represented by the following formula [I] wherein each symbol is as defined in the specification, a pharmaceutically acceptable salt thereof, and a pharmaceutical agent for the prophylaxis or treatment of a disease caused by undesirable cell proliferation, particularly an antitumor agent, which contains such compound. The compound of the present invention has superior undesirable cell proliferation suppressing action, particularly, an antitumor action, and is useful as an antitumor agent for the prophylaxis or treatment of cancer, antirheumatoid agent and the like. In addition, by the combined use with other antitumor agent such as alkylating agent, metabolism antagonist and the like, it can be a more effective antitumor agent.